Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Lanas

Showing results (81-90 of 270) with videos related to

Pageof 27
Sort By:
Current Pharmaceutical Design|September 16, 2015
A Balanced View of Efficacy and Safety of Aspirin in Cardiovascular DiseasesRubén Casado-Arroyo, Angel Lanas, Pedro Brugada
Expert Review of Clinical Pharmacology|August 25, 2018
NSAID induced gastrointestinal damage and designing GI-sparing NSAIDsGuillermo García-Rayado, Mercedes Navarro, Angel Lanas
World Journal of Gastrointestinal Pharmacology and Therapeutics|March 8, 2014
Aspirin, cyclooxygenase inhibition and colorectal cancerCarlos Sostres, Carla Jerusalen Gargallo, Angel Lanas
Current Pharmaceutical Design|October 8, 2003
Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tractAngel Lanas, Julián Panés, Josep M Piqué
Frontiers in Medicine|April 23, 2025
Artificial Intelligence in GI endoscopy: what to expectMaría Concepción Aso, Carlos Sostres, Angel Lanas
Current Medical Research and Opinion|June 2, 2017
Non-steroidal anti-inflammatory drug related upper gastrointestinal bleeding: types of drug use and patient profiles in real clinical practiceCarlos Sostres, Patrica Carrera-Lasfuentes, Angel Lanas
Arthritis Research & Therapy|November 26, 2013
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damageCarlos Sostres, Carla J Gargallo, Angel Lanas
Expert Review of Clinical Pharmacology|May 3, 2017
Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcersGuillermo García-Rayado, Carlos Sostres, Angel Lanas
Annals of the Rheumatic Diseases|May 26, 2010
Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA studyAngel Lanas, Jesús Tornero, José Luis Zamorano
World Journal of Gastroenterology|July 30, 2014
Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insightsCarlos Sostres, Carla Jerusalen Gargallo, Angel Lanas
Pageof 27

Showing results (81-90 of 270) with videos related to

Sort By:
Pageof 27
Current Pharmaceutical Design|September 16, 2015
A Balanced View of Efficacy and Safety of Aspirin in Cardiovascular DiseasesRubén Casado-Arroyo, Angel Lanas, Pedro Brugada
Expert Review of Clinical Pharmacology|August 25, 2018
NSAID induced gastrointestinal damage and designing GI-sparing NSAIDsGuillermo García-Rayado, Mercedes Navarro, Angel Lanas
World Journal of Gastrointestinal Pharmacology and Therapeutics|March 8, 2014
Aspirin, cyclooxygenase inhibition and colorectal cancerCarlos Sostres, Carla Jerusalen Gargallo, Angel Lanas
Current Pharmaceutical Design|October 8, 2003
Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tractAngel Lanas, Julián Panés, Josep M Piqué
Frontiers in Medicine|April 23, 2025
Artificial Intelligence in GI endoscopy: what to expectMaría Concepción Aso, Carlos Sostres, Angel Lanas
Current Medical Research and Opinion|June 2, 2017
Non-steroidal anti-inflammatory drug related upper gastrointestinal bleeding: types of drug use and patient profiles in real clinical practiceCarlos Sostres, Patrica Carrera-Lasfuentes, Angel Lanas
Arthritis Research & Therapy|November 26, 2013
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damageCarlos Sostres, Carla J Gargallo, Angel Lanas
Expert Review of Clinical Pharmacology|May 3, 2017
Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcersGuillermo García-Rayado, Carlos Sostres, Angel Lanas
Annals of the Rheumatic Diseases|May 26, 2010
Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA studyAngel Lanas, Jesús Tornero, José Luis Zamorano
World Journal of Gastroenterology|July 30, 2014
Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insightsCarlos Sostres, Carla Jerusalen Gargallo, Angel Lanas
Pageof 27